CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
The proLungPlasma project focuses on validating a blood test for lung cancer that detects specific DNA methylation markers. This test aims to reduce false positives in lung cancer screening, improving diagnostic accuracy and patient outcomes.
The objective of “proLungPlasma” is the clinical validation of a lung cancer test, which detects DNA methylation of the specific biomarker mSHOX2.
Methylation of DNA is an important epigenetic process involved in fundamental biological processes as development and cell differentiation.
Aberrant DNA methylation plays a major role in cancer development.
Epigenomics is very successfully engaged in epigenetic research since 1998 resulting in an outstanding proprietary platform for epigenetic biomar…
EPIGENOMICS AG
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
